Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs
Go back to Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs| (NASDAQ: MCRB) | Delayed: 5.72 +0.08 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.64 | 52 Week High | $44.51 | |||
| Open | $5.64 | 52 Week Low | $8.05 | |||
| Day High | $5.89 | P/E | N/A | |||
| Day Low | $5.58 | EPS | $0.00 | |||
| Volume | 36,449 | |||||
